InVivo Therapeutics reports narrowed 2014 losses

InVivo Therapeutics reports narrowed annual losses, due in part to changes in the market value of the company's derivative warrant liability.

(OTC:IVOB) reported a narrowed annual loss, due in part to changes in the market value of the company's derivative warrant liability.

InVivo Therapeutics Corp.

News Well, MassDevice.com Earnings Roundup, 2014, Regenerative Medicine, Spinal

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1LjPaiD